β2-microglobulin and cystatin C in type 2 diabetes: Assessment of diabetic nephropathy

Experimental and Clinical Endocrinology and Diabetes

Volumn 112, Issue 4, 2004, Pages 195-200

  Apakkan Aksun, S ^a   Ozmen D ^a   Ozmen B ^b   Parildar, Zuhal ^a   Mutaf, I ^a   Turgan, N ^a   Habif, S ^a   Kumanliogluc K ^a   Bayindir, O ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b CELAL BAYAR UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Beta 2 microglobulin; Cystatin C; Diabetic nephropathy; Type 2 diabetes

Indexed keywords

BETA 2 MICROGLOBULIN; CYSTATIN C; PENTETATE TECHNETIUM TC 99M; BIOLOGICAL MARKER; CREATININE; CYSTATIN; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; PROTEINURIA; ALBUMINURIA; BLOOD; EARLY DIAGNOSIS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; SCINTISCANNING;

ADULT; AGED; ALBUMINURIA; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CREATININE; CYSTATINS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EARLY DIAGNOSIS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M PENTETATE;

EID: 2442486661     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-817933     Document Type: Article

References (34)

1. Abrahamson M, Olafsson I, Palsdottir A, Ulvsback M, Lundwall A, Jensson O, Grubb A. Structure and expression of the human cystatin C gene. Biochem J 1990; 268: 287-294
2. Bianchi C, Donadio C, Tramonti G, Consani C, Lorusso P, Rossi G. Reappraisal of serum beta2-microglobulin as marker of GFR. Ren Fail 2001; 23: 419-429
3. Bökenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C - A new marker of glomerular filtration rate in children independent of age and height. Pediatrics 1998; 101: 875-881
4. Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A, Vera M, Piera C, Darnell A. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early impairment. Am J Kidney Dis 2000; 36: 29-34
5. Donadio C, Lucchesi A, Ardini L, Ardini M, Giordani R. Cystatin C, β2-microglobulin, and retinol-binding protein as indicators of glomerular filtration rate: comparison with plasma creatinine. J Pharm Biomed Anal 2001; 24: 835-842
6. Finney H, Newman DJ, Price CP. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem 2000; 37: 49-59
7. Grubb A, Simonsen O, Storfelt G, Truedsson L, Thysell H. Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand 1985; 218: 499-503
8. Hallab M, Gallois Y, Chatellier G, Rohmer V, Fressinaud P, Marre M. Comparison of reduction in microalbuminuria by enalapril and hydrocholorothiazide in normotensive patients with insulin dependent diabetes. Brit Med J 1993; 306: 175-182
9. Harmoinen AP, Kouri TT, Wirta OR, Lehtimaki TJ, Rantalaiho V, Turjanmaa VM, Pasternack AI. Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type 2 diabetes. Clin Nephrol 1999; 52: 363-370
10. Henne V, Frei P, Bürgisser P. Beta2-microglobulin - a rapid and automated determination for a broad range of clinical applications. Anticancer Res 1997; 17: 2915-2918
11. Henskens YM, Veerman EC, Nieuw Amerongen AV. Cystatins in health and disease. Biol Chem Hoppe-Seyler 1996; 377: 71-86
12. Jacobs C, Selwood NH. Renal replacement therapy for end-stage renal failure in France: Current status and evolutive trends over the last decade. Am J Kidney Dis 1995; 25: 188-195
13. Keevil BG, Kilpatrick ES, Nichols SP, Maylor PW. Biological variation of cystatin C. implications for the assessment of glomerular filtration rate. Clin Chem 1998; 44: 1535-1539
14. Konen JC, Shihabi ZK. Microalbuminuria and diabetes mellitus. American Family Physician 1993; 48: 421-1428
15. Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindstrom V, Grubb A. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 1994; 40: 1921-1926
16. Larsen K. Creatinine assay by a reaction-kinetic approach. Clin Chim Acta 1972; 41: 209-217
17. Mathiesen ER, Oxenbøll B, Johansen K, Svendsen PA, Deckert T. Incipient nephropathy in type 1 (insulin dependent) diabetes. Diabetologia 1984; 26: 406-410
18. Mogensen CE, Schimitz O. The diabetic kidney: from hyperfiltration and microalbuminuria to end-stage renal failure. Medicine Clinicals of North America 1988; 72: 1465-1492
19. Mojiminiyi OA, Abdella N, George S. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus. Scand J Clin Lab Invest 2000; 60: 483-489
20. Mussap M, Dalla Vestra M, Fioretto P, Saller A, Varagnolo M, Nosadini R, Plebani M. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int 2002; 61: 1453-1461
21. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP. Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995; 47: 312-318
22. Nolte S, Mueller B, Pringsheim W. Serum α1-microglobulin and beta2-microglobulin for the estimation of fetal glomerular renal function. Pediatr Nephrol 1991; 5: 573-577
23. Oberbauer R, Nenov V, Weidekamm C, Haas M, Szekeres T, Mayer G. Reduction in mean glomerular pore size coincides with the development of large shunt pores in patients with diabetic nephropathy. Exp Nephrol 2001; 9: 49-53
24. Oddoze C, Morange S, Portugal H, Berland Y, Dussol B. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes. Am J Kidney Dis 2001; 38: 310-316
25. Payne RB. Creatinine clearance: a redundant clinical investigation. Ann Clin Biochem 1986; 23: 243-250
26. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992; 38: 1933-1953
27. Piwowar A, Knapik-Kordecka M, Buczynska H, Warwas M. Plasma cystatin C concentration in non-insulin-dependent diabetes mellitus: relation with nephropathy. Arch Immunol Ther Exp (Warsz) 1999; 47: 327-331
28. Reddi AS. Glomerular and urinary glycosaminoglycans in diabetic rats. Clin Chim Acta 1990; 189: 211-220
29. Schardijn GHC, Statius van Eps LW. Beta 2-microglobulin: its significance in the evaluation of renal function. Kidney Int 1987; 32: 635-641
30. Schimitz A, Vaeth M, Mogensen CE. Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM. Diabetologia 1994; 37: 1251-1258
31. Spencer K. Analytical reviews of clinical biochemistry: the estimation of creatinine. Ann Clin Biochem 1986; 23: 1-25
32. Swan SK. The search continues - an ideal marker of GFR. Clin Chem 1997; 43: 913-914
33. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197
34. Vernier RL, Steffes MW, Sisson RS, Mauer SM. Heparan sulfate proteoglycan in the glomerular basement membrane in type I diabetes mellitus. Kidney Int 1992; 41: 1070-1080